Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

After starting my career at PCMag as an intern more than a decade ago, I’m back as one of its editors, focused on managing laptops, desktops, and components coverage. With 15 years of experience ...